Unibest

Pharmaceutical intermediates

Indacaterol Maleate Intermediates

3 pharmaceutical intermediates for Indacaterol Maleate. Indication: Pulmonary Disease, Chronic Obstructive.

提交项目All intermediates

About Indacaterol Maleate

Originator
Novartis Pharmaceuticals Corp
Indication
Pulmonary Disease, Chronic Obstructive
Approved Date
10/29/2015
DS/DP
02/25/2025

Available intermediates

3 intermediates currently listed for Indacaterol Maleate. Request specifications, documentation or a quotation for any item below.

Indacaterol Maleate intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
5,6-Diethyl-2,3-dihydro-1H-inden-2-amine hydrochloride312753-53-0//
8-Benzyloxy-5-(2-bromoacetyl)-2-hydroxyquinoline100331-89-3//
5-ACETYL-8-HYDROXY-1H-QUINOLIN-2-ONE62978-73-8//

Other programs under I

Ibrutinib/ Zanubrutinib IguratimodImatinibImeglimin hydrochlorideInfigratinibIpatacopan HydrochlorideIpragliflozinIrinotecan

Building toward Indacaterol Maleate?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →